How many studies have been conducted on Faecalibacterium Prausnitzii?

BiohacksAI has indexed 212 PubMed studies on Faecalibacterium Prausnitzii, including 7 randomized controlled trials (RCTs). 42% of studies involve human subjects.

What are the main research areas for Faecalibacterium Prausnitzii?

The primary research domains for Faecalibacterium Prausnitzii are 🦠 Gut & Microbiome, 🔬 Inflammation, 🔥 Metabolic. This is based on analysis of 212 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Faecalibacterium Prausnitzii

A species of FAECALIBACTERIUM, previously classified in the FUSOBACTERIUM genus, that is a major constituent of the GUT MICROBIOTA in healthy humans. It has anti-inflammatory activity and reduced numbers of this species occur in patients with INFLAMMATORY BOWEL DISEASES such as CROHN DISEASE.

212+ PubMed studies analyzed · 7 RCTs · Evidence Score: 51.7

Research Domains

Faecalibacterium Prausnitzii has been studied across 16 research domains including 🦠 Gut & Microbiome, 🔬 Inflammation, 🔥 Metabolic, 🛡️ Immunity, 🔬 Oncology. The primary research focus is 🦠 Gut & Microbiome with 64% of studies addressing this area.

Loading evidence profile...

This evidence profile for Faecalibacterium Prausnitzii is generated deterministically from 212 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.